20945 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for hormones
DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
#2USE OF APELIN FOR THE TREATMENT OF LYMPHEDEMA
#3COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#4COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#5METHODS AND COMPOSITIONS FOR TREATING MYELOFIBROSIS
#6COMPOSITIONS AND METHODS FOR MODULATING MOLECULES
#7INGESTIBLE DEVICE FOR DELIVERY OF THERAPEUTIC AGENT TO THE GASTROINTESTINAL TRACT
#8ANTIBODY-CONJUGATED NANOPARTICLES AND MEDICAL USES THEREOF
#9IONIC LIQUID FORMULATIONS FOR TREATING DIABETES
#10Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR)
#11Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof
#12ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS
#13TRANSDUCED T CELLS EXPRESSING HUMAN SSTR2 AND APPLICATION THEREOF
#14COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#15NOVEL RECOMBINANT EXOSOME AND USE THEREOF
#16LIQUID FORMULATION
#17ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT
#18SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#19SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING RENAL DISEASES OR CONDITIONS
#20COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#21IDENTIFICATION OF AN EGFR-BIN3 PATHWAY THAT ACTIVELY SUPPRESSES INVASION AND REDUCES TUMOR SIZE IN GLIOBLASTOMA
#22COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN THE TREATMENT OF NASH/NAFLD AND RELATED DISEASES
#23DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
#24PHARMACEUTICAL COMPOSITION COMPRISING VACCINIA VIRUS AND HYDROXYUREA AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER
#25COMPOSITIONS AND METHODS OF TREATMENT FOR BREAST CANCER INVOLVING A NOVEL CAPER?-MLL1 COMPLEX
#26PARATHYROID HORMONE FUSION POLYPEPTIDE
#27COMPOSITIONS AND IMPLANTABLE DEVICES
#28ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS
#29Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
#30IMPLANTABLE POLYMER DEPOTS FOR THE CONTROLLED, SUSTAINED RELEASE OF THERAPEUTIC AGENTS
#31METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS
#32ISOLATED GDF TRAP POLYPEPTIDE
#33THERAPEUTIC USE OF TRIGONAL GLUCAGON/GLP-1/GIP RECEPTOR AGONIST OR CONJUGATE THEREOF FOR LIVER DISEASE
#34METHODS FOR INCREASING THERMOGENIC ADIPOCYTES
#35RELAXIN RECEPTOR 1 FOR USE IN TREATMENT AND PREVENTION OF HEART FAILURE
#36ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS
#37MODIFIED CHANNEL RHODOPSIN
#38INTRANASAL ADMINISTRATION
#39GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
#40Methods and compositions for treating myelofibrosis
#41COMPOSITIONS ACTING AS PRO(RENIN) RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
#42I DOMAIN CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO ICAM-1
#43Compositions and methods for treating pulmonary hypertension
#44Universal nanosponge for treating respiratory viral infection
#45Compositions and methods for treating pulmonary hypertension
#46Methods and Compositions for Regulating an Immune Response
#47METHODS FOR TREATING FATTY LIVER DISEASE
#48ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING MULTIPLE MYELOMA
#49COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS
#50METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING POLYCYSTIC OVARY SYNDROME
#51Fusion protein comprising thyrotropin receptor variants and use thereof
#52Cholix-derived carriers for oral delivery of heterologous payload
#53SUSTAINED-RELEASE DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A CNP COMPOUND, AN NPR-B COMPOUND, A TIE-2 AGONIST, OR NEUROTROPHIC AGENT FOR USE FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
#54COMPOSITIONS AND METHOD FOR REDUCING SEIZURES
#55COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HYPERGLYCEMIA, INSULIN RESISTANCE, AND ASSOCIATED ORGAN DAMAGE
#56Macrophage stimulating 1 receptor (MST1R) variants and uses thereof
#57METHODS FOR DOSING AN ACTIVIN-ACTRIIA ANTAGONIST AND MONITORING OF TREATED PATIENTS
#58Compositions and methods for treating pulmonary hypertension
#59Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
#60Compositions and methods for treating pulmonary hypertension
#61Compositions and methods for treating pulmonary hypertension
#62Compositions and methods for treating pulmonary hypertension
#63Compositions and methods for treating pulmonary hypertension
#64FGF21 C-terminal peptide optimization
#65METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS
#66Polynucleotides encoding relaxin
#67METHODS FOR TREATING PSORIASIS
#68Methods for treating anemia in a subject in need thereof
#69Methods for treating anemia in a subject in need thereof
#70Methods for treating anemia in a subject in need thereof
#71ISOLATED GDF TRAP POLYPEPTIDE
#72Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
#73Transduced T cells expressing human SSTR2 and application thereof
#74Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#75Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#76ISOLATED GDF TRAP POLYPEPTIDE
#77METHODS FOR IMPROVING SEX-DIMORPHIC RESPONSES TO TARGETED THERAPY IN MELANOMA
#78Parathyroid hormone fusion polypeptide
#79Methods for screening compounds for increasing thermogenic adipocytes
#80Anti-PACAP antibody
#81Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour
#82Administration of an anti-activin-A compound to a subject
#83Methods for treating vascular eye disorders with ActRII antagonists
#84Compositions and methods for treating and/or preventing pathogenic fungal infection and for maintenance of microbiome commensalism
#85THERAPEUTIC METHOD USING TOLEROGENIC PEPTIDES
#86ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS
#87I domain chimeric antigen receptor specific to ICAM-1
#88ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS
#89Methods for treating psoriasis
#90Methods of treating diseases resulting from a maladapted stress response
#91CELL EXPRESSING CAR AND GPCR
#92ANTIBODY-CONJUGATED NANOPARTICLES AND MEDICAL USES THEREOF
#93Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
#94ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS
#95PAC1 antibodies and uses thereof
#96Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor
#97FGF21 C-TERMINAL PEPTIDE OPTIMIZATION
#98GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof
#99INTRANASAL ADMINISTRATION
#100Anti-PACAP antibody
#101METHODS FOR TREATING FATTY LIVER DISEASE
#102A NOVEL LIQUID FORMULATION OF LONG-ACTING HUMAN GROWTH HORMONE CONJUGATE
#103Polynucleotides encoding relaxin
#104Methods and compositions for promoting thermogenic potential
#105Mammalian EphA4 polypeptide derivatives lacking one or more N-glycosylation sites and method of use thereof
#106Method of treating a vasculopathy in a human subject
#107Methods of treating or preventing pruritis by blocking natriuretic polypeptide b
#108METHODS FOR TREATING REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS
#109Identification of cyclic peptide agonists of galanin receptor 2 and 3 guided by spexin solution structure
#110Thyroid stimulating hormone receptor peptides and uses thereof
#111Compositions and methods for treating pulmonary hypertension
#112METHODS FOR INCREASING THERMOGENIC ADIPOCYTES
#113Compositions and method for reducing seizures
#114Transduced T cells expressing human SSTR2 and application thereof
#115I domain chimeric antigen receptor specific to ICAM-1
#116Compositions and methods for treating pulmonary hypertension
#117METHODS FOR TREATING MELANOMA
#118Methods for treating refractory anemia with ringed sideroblasts
#119Methods of lowering serum cholesterol
#120Methods for treating vascular eye disorders with actrii antagonists
#121REPOPULATION OF ORGANS AND TISSUES USING A YAP-ERT2 FUSION PROTEIN
#122Blood glucose lowering compound
#123Methods of identifying ActRIIB variants
#124Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases
#125MODULATION OF ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) AND USES THEREFOR
#126METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS
#127PAR-1 based therapeutic conjugates and uses thereof
#128Methods of treating or preventing pruritis by blocking natriuretic polypeptide B
#129Isolated nucleotide sequences encoding GDF traps
#130LEPTIN IN IMMUNE MODULATION
#131METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS
#132Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands
#133Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
#134Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
#135Activin-ActRII antagonists and uses for treating bone and other disorders
#136COMBINATION PRODUCTS FOR TREATING CANCER
#137Intranasal administration
#138Follistatin fusion proteins and uses thereof
#139MODULATION OF ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) AND USES THEREFOR
#140Methods for increasing thermogenic adipocytes
#141Isolated nucleotide sequences encoding GDF traps
#142Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
#143Use of GDF traps to treat anemia
#144ACTRIIB-FC polynucleotides, polypeptides, and compositions
#145Activin-actriia antagonists and uses for treating multiple myeloma
#146Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor
#147Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#148MEANS AND METHODS FOR TREATING ISCHEMIC CONDITIONS
#149Methods for increasing thermogenic adipocytes
#150ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS
#151Isolated GDF trap polypeptide
#152Methods for decreasing leptin levels or activity for treating inflammation
#153ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR
#154Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells
#155Methods of treating cancer using the calcitonin-gene related peptide (“CGRP”) receptor antagonist CGRP8-37
#156METHODS FOR TREATING FATTY LIVER DISEASE
#157INTRANASAL ADMINISTRATION
#158FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
#159Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
#160Methods for increasing thermogenic adipocytes
#161LIGAND OF REGULATING IMMUNE RESPONSE, AND USE THEREOF IN TREATING AN IMMUNE RESPONSE-RELATED DISEASE
#162ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) IN BONE AND CARTILAGE FORMATION AND METHODS AND COMPOSITIONS RELATING TO SAME
#163Actriib-Fc polynucleotides, polypeptides, and compositions
#164Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy
#165COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#166Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#167Activin-actrii antagonists and uses for increasing red blood cell levels
#168Estrogen Related Receptor, ERRalpha, A Regulator of Bone Formation
#169Molecules and methods for treatment and detection of cancer
#170Method of increasing red blood cell levels or treating anemia in a patient
#171Methods for dosing an activin-actriia antagonist and monitoring of treated patients
#172Methods for dosing an actriib antagonist and monitoring of treated patients
#173Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1)
#174FUNCTIONS AND USES OF GPR39 GENE IN MAMMALIAN CENTRAL NERVOUS SYSTEM
#175MEDICAL DEVICE FOR TREATING DIABETES MELLITUS, OBESITY, CHRONIC FATIGUE, AGING, AND OTHER MEDICAL CONDITIONS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT MESSENGER RIBONUCLEIC ACID MOLECULES INTO CELLS
#176COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#177Stimulating G Protein-Coupled Receptors
#178Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity
#179Activin-actrii antagonists and uses for increasing red blood cell levels
#180Activin-ActRIIa antagonists and uses for treating multiple myeloma
#181Isolated nucleic acids encoding soluble corticotropin releasing factor receptor type 2 (sCRFR2) polypeptides
#182Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity
#183ActRIIB Fusion Polypeptides and Uses Therefor
#184ActRIIB Fusion Polypeptides and Uses Therefor
#185Method for screening substance having proangiogenic effect
#186Activin-actriia antagonists and uses for treating or preventing breast cancer
#187Activin-ActRII antagonists and uses for increasing red blood cell levels
#188Compositions and methods for the treatment of respiratory disorders
#189Methods of screening for compounds which bind G protein-coupled receptors
#190Methods and Compositions Involving A1c Subunit of L-Type Calcium Channels in Smooth Muscle Cells
#191Methods and Compositions for Diagnosis and Treatment of Disorders Involving Macrophages
#192Vector system
#193ActRIIB Fusion Polypeptides and Uses Therefor
#194Compositions and Methods that Enhance Articular Cartilage Repair
#195Methods for treating irritable bowel syndrome
#196Isolated soluble corticotropin releasing factor receptor type 2 (sCRFR2)
#197Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
#198Compositions and methods for modulating body weight and treating obesity-related disorders
#199Methods for manipulating satiety
#200Estrogen related receptor, ERRα, a regulator of bone formation
#201Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#202Enhancement of adenoviral oncolytic activity by modification of the E1A gene product
#203Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#204Melanocortin receptor binding mimetibodies, compositions, methods and uses
#205ActRII receptor polypeptides, methods and compositions
#206Methods of prevention and treatment of asthma, and allergic conditions
#207Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#208Methods of prevention and treatment of asthama, and allergic conditions
#209Methods of prevention and treatment of asthma, and allergic conditions